Dipna Pharmachem Ltd is in the business of Pharmaceutical TradingBusiness Overview: DPL is a trader, importer, and exporter of industrial Chemical and Pharmaceutical Raw materials, APIs, Solvents, Excipients, Intermediates, and Formulations. It provides assistance in setting up contract manufacturing compliance for regulated, semi-regulated pharmaceutical companies with all the global benchmark...
Dipna Pharmachem Limited has submitted a compliance certificate from its Registrar and Share Transfer Agent for the quarter ending June 30. The certificate confirms that no physical shares were received for dematerialization during this period. This means there were no conversions of physical shares into electronic form, and consequently, no...
Dipna Pharmachem Limited has published extracts of its audited financial results for the quarter and year ended 31st March 2026 in both English and regional language editions of the Financial Express newspaper. This public disclosure is a crucial compliance step, ensuring all stakeholders have timely access to the company's latest...
Dipna Pharmachem Limited has reported its audited financial results for the quarter and year ended March 31, 2026. For the full year, the company achieved revenue of Rs 129.08 Cr and a net profit of Rs 2.63 Cr, with basic EPS at Rs 1.00. For the quarter, revenue stood at...
DIPNA PHARMACHEM LIMITED has announced that its board approved the audited financial results for the quarter and year ended March 31, 2026. The company reported a net profit of Rs. 2.63 Cr for the year and Rs. 0.18 Cr for the quarter. Revenue from operations for the year stood at...
Dipna Pharmachem Limited announced that Mr. Nandish Shaileshbhai Jani has resigned from his position as a Non-Executive and Independent Director, effective 10th June, 2026. Mr. Jani stated personal reasons, specifically his inability to devote adequate time to company matters, as the cause for his departure. He confirmed that no other...
